Risk Factors for Valvulopathy Among Childhood Cancer Survivors
JAMA Oncology 10.1001/jamaoncol.2025.3863October 09, 2025 at 11:00 AM EDT
Which treatments are associated with increased risk of symptomatic valvular heart disease (VHD) in long-term childhood cancer survivors?In this case-control study of 225 case patients and 442 controls, heart radiation therapy, high cumulative anthracycline doses, and exposure to platinum agents were associated with increased VHD risk. The heart radiation therapy dose response was exponential, and the risk increased with longer follow-up.The risk for VHD appears more strongly concentrated at high doses of heart radiation and anthracyclines, with exponential dose-response associations observed for both exposures.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.